Moreover, PCK1 and p-RhoA (S188) were downregulated in samples from patients with NASH, whereas p-AKT (S473) and PDGF-AA levels were upregulated (Fig. 7k, l). Here, AKT1 is linked to metabolic dysfunction-associated steatohepatitis.